Targeting gut and intratumoral microbiota: a novel strategy to improve therapy resistance in cancer with a focus on urologic tumors

Bingquan Wu,Chao Quan,Yunbo He,Juliet Matsika,Jinliang Huang,Bolong Liu,Jinbo Chen
DOI: https://doi.org/10.1080/14712598.2024.2371543
2024-06-25
Expert Opinion on Biological Therapy
Abstract:Introduction Growing attention has been drawn to urologic tumors due to their rising incidence and suboptimal clinical treatment outcomes. Cancer therapy resistance poses a significant challenge in clinical oncology, limiting the efficacy of conventional treatments and contributing to disease progression. Recent research has unveiled a complex interplay between the host microbiota and cancer cells, highlighting the role of the microbiota in modulating therapeutic responses.
medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?